Atomo Diagnostics Limited (ASX:AT1)
Australia · Delayed Price · Currency is AUD 0.0290
+0.0020 (7.41%)
Nov 14, 2025, 3:16 PM AEST
Atomo Diagnostics Market Cap
Atomo Diagnostics has a market cap or net worth of 23.5 million as of November 14, 2025. Its market cap has increased by 83.78% in one year.
Market Cap
23.50M
Enterprise Value
20.46M
Revenue
3.79M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.03
Market Cap Chart
Since April 16, 2020, Atomo Diagnostics's market cap has decreased from 218.82M to 23.50M, a decrease of -89.26%. That is a compound annual growth rate of -32.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 14, 2025 | 23.50M | 93.46% |
| Dec 31, 2024 | 12.14M | -13.64% |
| Dec 29, 2023 | 14.06M | -54.38% |
| Dec 30, 2022 | 30.83M | -81.93% |
| Dec 31, 2021 | 170.58M | -1.08% |
| Dec 31, 2020 | 172.45M | -21.19% |
| Apr 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 86.09B |
| Pro Medicus | 26.64B |
| Cochlear | 18.86B |
| Sonic Healthcare | 10.41B |
| Ramsay Health Care | 7.08B |
| Telix Pharmaceuticals | 5.29B |
| Ansell | 5.22B |
| Mesoblast | 2.96B |